Group One Trading, L.P. Mesoblast LTD Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.39 $95,074 - $132,152	95,074 Added 143.3%	161,421 $177,000
Q3 2023 Nov 09, 2023	SELL	$1.22 - $4.83 $224,484 - $888,739	-184,004 Reduced 73.5%	66,347 $81,000
Q2 2023 Aug 09, 2023	BUY	$2.95 - $4.44 $292,581 - $440,359	99,180 Added 65.61%	250,351 $978,000
Q1 2023 May 12, 2023	BUY	$2.94 - $4.18 $38,264 - $54,402	13,015 Added 9.42%	151,171 $497,000
Q4 2022 Feb 09, 2023	SELL	$2.73 - $3.7 $45,159 - $61,205	-16,542 Reduced 10.69%	138,156 $402,000
Q3 2022 Nov 09, 2022	BUY	$0.48 - $3.48 $69,239 - $501,983	144,248 Added 1380.36%	154,698 $394,000
Q2 2022 Aug 11, 2022	BUY	$2.22 - $4.54 $23,199 - $47,443	10,450 New	10,450 $23,000
Q3 2021 Nov 12, 2021	SELL	$5.87 - $7.85 $129,363 - $172,998	-22,038 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$6.69 - $9.0 $147,434 - $198,342	22,038 New	22,038 $165,000
Q3 2020 Nov 12, 2020	SELL	$11.33 - $19.81 $148,592 - $259,808	-13,115 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$4.2 - $15.45 $63,865 - $234,932	-15,206 Reduced 53.69%	13,115 $149,000
Q1 2020 May 13, 2020	BUY	$3.38 - $10.63 $36,348 - $114,315	10,754 Added 61.22%	28,321 $124,000
Q3 2019 Nov 12, 2019	BUY	$4.68 - $7.42 $82,213 - $130,347	17,567 New	17,567 $122,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.